Journal of Neuroimmunology
Volume 217, Issue 1 , Pages 14-19 , 10 December 2009

Ischemic preconditioning-induced neuroprotection is associated with differential expression of IL-1β and IL-1 receptor antagonist in the ischemic cortex

  • Jin A. Shin

      Affiliations

    • Department of Pharmacology, Ewha Medical Research Institute, School of Medicine, Ewha Womans University, 911-1 Mok6dong Yangcheon-gu, Seoul, 158-710, Republic of Korea
    • ,
  • Eun-Mi Park

      Affiliations

    • Department of Pharmacology, Ewha Medical Research Institute, School of Medicine, Ewha Womans University, 911-1 Mok6dong Yangcheon-gu, Seoul, 158-710, Republic of Korea
    • Corresponding Author InformationCorresponding author. Tel.: +82 2 2650 5743; fax: +82 2 2653 8891.
    • ,
  • Ji-Seung Choi

      Affiliations

    • Department of Pharmacology, Ewha Medical Research Institute, School of Medicine, Ewha Womans University, 911-1 Mok6dong Yangcheon-gu, Seoul, 158-710, Republic of Korea
    • ,
  • Sun-Mi Seo

      Affiliations

    • Department of Pharmacology, Ewha Medical Research Institute, School of Medicine, Ewha Womans University, 911-1 Mok6dong Yangcheon-gu, Seoul, 158-710, Republic of Korea
    • ,
  • Jihee Lee Kang

      Affiliations

    • Department of Physiology, Ewha Medical Research Institute, School of Medicine, Ewha Womans University, Seoul, Republic of Korea
    • ,
  • Kyung-Eun Lee

      Affiliations

    • Department of Pharmacology, Ewha Medical Research Institute, School of Medicine, Ewha Womans University, 911-1 Mok6dong Yangcheon-gu, Seoul, 158-710, Republic of Korea
    • ,
  • Sunghee Cho

      Affiliations

    • Burke Medical Research Institute, White Plains, New York, United States
    • Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, New York, United States

Received 13 March 2009 ,Revised 22 May 2009 ,Accepted 1 June 2009.

References 

  1. Allan SM, Tyrrell PJ, Rothwell NJ. Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 2005;5:629–640
  2. Arend WP. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev. 2002;13:323–340
  3. Barone FC, White RF, Spera PA, Ellison J, Currie RW, Wang X, et al. Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke. 1998;29:1937–1950
  4. Barrier A, Olaya N, Chiappini F, Roser F, Scatton O, Artus C, et al. Ischemic preconditioning modulates the expression of several genes, leading to the overproduction of IL-1Ra, iNOS, and Bcl-2 in a human model of liver ischemia-reperfusion. FASEB J. 2005;19:1617–1626
  5. Betz AL, Yang GY, Davidson BL. Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J. Cereb. Blood Flow Metab. 1995;15:547–551
  6. Bowen KK, Naylor M, Vemuganti R. Prevention of inflammation is a mechanism of preconditioning-induced neuroprotection against focal cerebral ischemia. Neurochem. Int. 2006;49:127–135
  7. Cho S, Park EM, Zhou P, Frys K, Ross ME, Iadecola C. Obligatory role of inducible nitric oxide synthase in ischemic preconditioning. J. Cereb. Blood Flow Metab. 2005;25:493–501
  8. Choi JS, Kim SJ, Shin JA, Lee KE, Park EM. Effects of estrogen on temporal expressions of IL-1β and IL-1ra in rat organotypic hippocampal slices exposed to oxygen-glucose deprivation. Neurosci. Lett. 2008;438:233–237
  9. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22:391–397
  10. Dirnagl U, Meisel A. Endogenous neuroprotection: mitochondria as gateways to cerebral preconditioning?. Neuropharmacology. 2008;55:334–344
  11. Dirnagl U, Simon RP, Hallenbeck JM. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci. 2003;26:248–254
  12. Gidday JM. Cerebral preconditioning and ischaemic tolerance. Nat. Rev. Neurosci. 2006;7:437–448
  13. Kirino T. Ischemic tolerance. J. Cereb. Blood Flow Metab. 2002;22:1283–1296
  14. Kitagawa K, Matsumoto M, Tagaya M, Hata R, Ueda H, Niinobe M, et al ‘Ischemic tolerance’ phenomenon found in the brain. Brain Res. 1990;528:21–24
  15. Legos JJ, Whitmore RG, Erhardt JA, Parsons AA, Tuma RF, Barone FC. Quantitative changes in interleukin proteins following focal stroke in the rat. Neurosci. Lett. 2000;282:189–192
  16. Lin TN, He YY, Wu G, Khan M, Hsu CY. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke. 1993;24:117–121
  17. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–408
  18. Loddick SA, Rothwell NJ. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J. Cereb. Blood Flow Metab. 1996;16:932–940
  19. Loddick SA, Wong ML, Bongiorno PB, Gold PW, Licinio J, Rothwell NJ. Endogenous interleukin-1 receptor antagonist is neuroprotective. Biochem. Biophys. Res. Commun. 1997;234:211–215
  20. Martin D, Chinookoswong N, Miller G. The interleukin-1 receptor antagonist (rhIL-1ra) protects against cerebral infarction in a rat model of hypoxia–ischemia. Exp. Neurol. 1994;130:362–367
  21. Mulcahy NJ, Ross J, Rothwell NJ, Loddick SA. Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat. Br. J. Pharmacol. 2003;140:471–476
  22. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124–1136
  23. O'Connor K, Johnson J, Hansen M, Wieseler Frank J, Maksimova E, Watkins L, et al. Peripheral and central proinflammatory cytokine response to a severe acute stressor. Brain Res. 2003;991:123–132
  24. Ohtsuki T, Ruetzler CA, Tasaki K, Hallenbeck JM. Interleukin-1 mediates induction of tolerance to global ischemia in gerbil hippocampal CA1 neurons. J. Cereb. Blood Flow Metab. 1996;16:1137–1142
  25. Palin K, Verrier D, Tridon V, Hurst J, Perry V, Dantzer R, et al. Influence of the course of brain inflammation on the endogenous IL-1β /IL-1Ra balance in the model of brain delayed-type hypersensitivity response to bacillus Calmette–Guérin in Lewis rats. J. Neuroimmunol. 2004;149:22–30
  26. Park EM, Cho BP, Volpe BT, Cruz MO, Joh TH, Cho S. Ibuprofen protects ischemia-induced neuronal injury via up-regulating interleukin-1 receptor antagonist expression. Neuroscience. 2005;132:625–631
  27. Park EM, Cho S, Frys K, Racchumi G, Zhou P, Anrather J, et al. Interaction between inducible nitric oxide synthase and poly(ADP-ribose) polymerase in focal ischemic brain injury. Stroke. 2004;35:2896–2901
  28. Pasupathy S, Homer-Vanniasinkam S. Ischaemic preconditioning protects against ischaemia/reperfusion injury: emerging concepts. Eur. J. Vasc. Endovasc. Surg. 2005;29:106–115
  29. Pera J, Zawadzka M, Kaminska B, Szczudlik A. Influence of chemical and ischemic preconditioning on cytokine expression after focal brain ischemia. J. Neurosci. Res. 2004;78:132–140
  30. Pinteaux E, Rothwell NJ, Boutin H. Neuroprotective actions of endogenous interleukin-1 receptor antagonist (IL-1ra) are mediated by glia. Glia. 2006;53:551–556
  31. Relton JK, Rothwell NJ. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res. Bull. 1992;29:243–246
  32. Swain JL, Sabina RL, Hines JJ, Greenfield JC, Holmes EW. Repetitive episodes of brief ischaemia (12 min) do not produce a cumulative depletion of high energy phosphate compounds. Cardiovasc. Res. 1984;18:264–269
  33. Valero N, MarinaEspina L, Bonilla E, Mosquera J. Melatonin decreases nitric oxide production and lipid peroxidation and increases interleukin-1 beta in the brain of mice infected by the Venezuelan equine encephalomyelitis virus. J. Pineal Res. 2007;42:107–112
  34. Wang X, Barone FC, Aiyar NV, Feuerstein GZ. Interleukin-1 receptor and receptor antagonist gene expression after focal stroke in rats. Stroke. 1997;28:155–161
  35. Wang X, Li X, Currie RW, Willette RN, Barone FC, Feuerstein GZ. Application of real-time polymerase chain reaction to quantitate induced expression of interleukin-1beta mRNA in ischemic brain tolerance. J. Neurosci. Res. 2000;59:238–246
  36. Yamasaki Y, Matsuura N, Shozuhara H, Onodera H, Itoyama Y, Kogure K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke. 1995;26:676–680

PII: S0165-5728(09)00215-X

doi: 10.1016/j.jneuroim.2009.06.001

Journal of Neuroimmunology
Volume 217, Issue 1 , Pages 14-19 , 10 December 2009

Article Tools

* Image Usage & Resolution